205 related articles for article (PubMed ID: 6331304)
1. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
Field HJ; Lay E
Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
[TBL] [Abstract][Full Text] [Related]
2. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
Sakuma S; Yamamoto M; Kumano Y; Mori R
Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
Tenser RB; Gaydos A; Hay KA
J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
Christophers J; Sutton RN
J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
Collins P; Ellis MN
J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
[TBL] [Abstract][Full Text] [Related]
6. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
Efstathiou S; Kemp S; Darby G; Minson AC
J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
Liu WG; Chen ZJ; Song JZ; Ma ZX
Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
Al-Saadi SA; Gross P; Wildy P
J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.
Field HJ; Darby G
Antimicrob Agents Chemother; 1980 Feb; 17(2):209-16. PubMed ID: 6247969
[TBL] [Abstract][Full Text] [Related]
12. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
[TBL] [Abstract][Full Text] [Related]
13. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
14. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
Larder BA; Darby G
Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
Nugier F; Colin JN; Aymard M; Langlois M
J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
[TBL] [Abstract][Full Text] [Related]
16. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
17. Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir.
Oliver NM; Collins P; Van der Meer J; Van't Wout JW
Antimicrob Agents Chemother; 1989 May; 33(5):635-40. PubMed ID: 2546486
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
Gateley A; Gander RM; Johnson PC; Kit S; Otsuka H; Kohl S
J Infect Dis; 1990 Apr; 161(4):711-5. PubMed ID: 2156946
[TBL] [Abstract][Full Text] [Related]
19. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
20. Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice.
Sarisky RT; Bartus HR; Dennis SA; Quail MR; Nguyen TT; Wittrock RJ; Halsey WS; Bacon TH; Leary JJ; Sutton D
BMC Infect Dis; 2001; 1():24. PubMed ID: 11749671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
